Pando uses AI-driven protein design and an ultra‑high‑throughput one‑pot screening platform to engineer enzymes with improved activity, stability, and manufacturability. It offers proprietary engineered enzymes for molecular biology workflows and custom enzyme development services that reduce costs and increase productivity for biotech companies and research labs.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Enzyme optimization is a slow, costly process because improving multiple properties such as activity, stability, and manufacturability requires extensive trial‑and‑error testing. Inefficient enzymes lead to higher production costs and lost market opportunities for molecular biology workflows.
Solution
Pando applies AI-driven protein design combined with an ultra‑high‑throughput one‑pot screening platform to engineer enzymes with superior performance across multiple criteria. Their protein‑specific models are trained on both public and proprietary datasets, enabling rapid identification of beneficial mutations. The integrated workflow shortens the design‑build‑test‑learn cycle to under a month, delivering engineered enzymes that exhibit higher activity, increased thermostability, low error rates, and commercial‑grade scalability. Pando offers both proprietary engineered enzymes for immediate use and custom enzyme development services to meet specific client needs.
Target Audience
Primary customers are biotech companies, molecular biology reagent manufacturers, and research laboratories that require high‑performance enzymes for DNA amplification, cloning, and other enzymatic workflows.
Features
- AI models that generate and evaluate enzyme variants for simultaneous improvement of activity, stability, and manufacturability
- Ultra‑high‑throughput one‑pot screening that converts diverse biological signals into large, quantitative datasets for rapid testing
- Continuous learning loop where screening data feed back into the AI, achieving hit rates two orders of magnitude higher than public‑data‑only models
- Engineered PD‑Phi29 DNA polymerase with increased activity up to 42 °C, high processivity, and error rates comparable to market leaders
- Custom enzyme design service that delivers tailored solutions to reduce costs and boost productivity in molecular biology applications